Hugo Gutiérrez-de-Terán (Hugo Gutierrez-de-Teran, Hugo Gutiérrez-de-Teran, Hugo Gutierrez de Teran)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 31

Top Venues

Journal of medicinal chemistry

Scientific reports

bioRxiv : the preprint server for biology

Biochemistry

Uppsala Universitet

Universitat Pompeu Fabra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uppsala Universitet May 01 2015

Sweden

Associate professor :: cell and molecular biology

Uppsala Universitet Jan 01 2013 - May 01 2015

Sweden

Researcher :: cell and molecular biology

Fundación Pública Galega de Medicina Xenómica Jan 01 2008 - Dec 31 2012

Spain

Parga Pondal Research Fellow - Head of Bioinformatics lab

Universidade de Santiago de Compostela Sep 01 2006 - Dec 31 2007

Spain

Data analysis manager :: pharmacology

Education History

Universitat Pompeu Fabra Sep 01 2000 - May 04 2004

Spain

PHD :: experimental and life sciences

Universidade de Santiago de Compostela Sep 01 1994 - Jul 01 1999

Spain

MSC

Publications

Kara Anazia, Lucien Koenekoop, Guillaume Ferré, Enzo Petracco, Hugo Gutiérrez-de-Terán, Matthew T Eddy
Visualizing the impact of disease-associated mutations on G protein-nucleotide interactions. bioRxiv : the preprint server for biology (2024)
Kara Anazia, Lucien Koenekoop, Guillaume Ferré, Enzo Petracco, Hugo Gutiérrez-de-Terán, Matthew T Eddy
Visualizing the impact of disease-associated mutations on G protein-nucleotide interactions. bioRxiv : the preprint server for biology (2024)
Apple Hui Min Tay, Rubén Prieto-Díaz, Shiyong Neo, Le Tong, Xinsong Chen, Valentina Carannante, Björn Önfelt, Johan Hartman, Felix Haglund, Maria Majellaro, Jhonny Azuaje, Xerardo Garcia-Mera, Jose M Brea, Maria I Loza, Willem Jespers, Hugo Gutiérrez-de-Terán, Eddy Sotelo, Andreas Lundqvist
A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models. Journal for immunotherapy of cancer 10 (5) (2022)
Rubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo, Jhonny Azuaje, Abdelaziz El Maatougui, Maria Majellaro, Maria Isabel Loza, Jose Brea, Víctor Fernández-Dueñas, M Rita Paleo, Alejandro Díaz-Holguín, Beatriz García-Pinel, Ana Mallo-Abreu, Juan C Estévez, Antonio Andújar-Arias, Xerardo García-Mera, Iria Gomez-Tourino, Francisco Ciruela, Cristian O Salas, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Exploring the Effect of Halogenation in a Series of Potent and Selective A 2B Adenosine Receptor Antagonists. Journal of medicinal chemistry 66 (1) (2022)
Rubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo, Jhonny Azuaje, Abdelaziz El Maatougui, Maria Majellaro, Maria Isabel Loza, Jose Brea, Víctor Fernández-Dueñas, M Rita Paleo, Alejandro Díaz-Holguín, Beatriz García-Pinel, Ana Mallo-Abreu, Juan C Estévez, Antonio Andújar-Arias, Xerardo García-Mera, Iria Gomez-Tourino, Francisco Ciruela, Cristian O Salas, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Exploring the Effect of Halogenation in a Series of Potent and Selective A 2B Adenosine Receptor Antagonists. Journal of medicinal chemistry 66 (1) (2022)
Cristina Val, Carlos Rodríguez-García, Rubén Prieto-Díaz, Abel Crespo, Jhonny Azuaje, Carlos Carbajales, Maria Majellaro, Alejandro Díaz-Holguín, José M Brea, Maria Isabel Loza, Claudia Gioé-Gallo, Marialessandra Contino, Angela Stefanachi, Xerardo García-Mera, Juan C Estévez, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A 1 Antagonists. Journal of medicinal chemistry 65 (3) (2022)
Darío Miranda-Pastoriza, Rodrigo Bernárdez, Jhonny Azuaje, Rubén Prieto-Díaz, Maria Majellaro, Ashish V Tamhankar, Lucien Koenekoop, Alejandro González, Claudia Gioé-Gallo, Ana Mallo-Abreu, José Brea, Maria Isabel Loza, Aitor García-Rey, Xerardo García-Mera, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Exploring Non-orthosteric Interactions with a Series of Potent and Selective A 3 Antagonists. ACS medicinal chemistry letters 13 (2) (2022)
Rubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo, Jhonny Azuaje, Abdelaziz El Maatougui, Maria Majellaro, Maria Isabel Loza, Jose Brea, Víctor Fernández-Dueñas, M Rita Paleo, Alejandro Díaz-Holguín, Beatriz García-Pinel, Ana Mallo-Abreu, Juan C Estévez, Antonio Andújar-Arias, Xerardo García-Mera, Iria Gomez-Tourino, Francisco Ciruela, Cristian O Salas, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Exploring the Effect of Halogenation in a Series of Potent and Selective A 2B Adenosine Receptor Antagonists. Journal of medicinal chemistry 66 (1) (2022)
Rubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo, Jhonny Azuaje, Abdelaziz El Maatougui, Maria Majellaro, Maria Isabel Loza, Jose Brea, Víctor Fernández-Dueñas, M Rita Paleo, Alejandro Díaz-Holguín, Beatriz García-Pinel, Ana Mallo-Abreu, Juan C Estévez, Antonio Andújar-Arias, Xerardo García-Mera, Iria Gomez-Tourino, Francisco Ciruela, Cristian O Salas, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Exploring the Effect of Halogenation in a Series of Potent and Selective A 2B Adenosine Receptor Antagonists. Journal of medicinal chemistry (2022)
Rubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo, Jhonny Azuaje, Abdelaziz El Maatougui, Maria Majellaro, Maria Isabel Loza, Jose Brea, Víctor Fernández-Dueñas, M Rita Paleo, Alejandro Díaz-Holguín, Beatriz García-Pinel, Ana Mallo-Abreu, Juan C Estévez, Antonio Andújar-Arias, Xerardo García-Mera, Iria Gomez-Tourino, Francisco Ciruela, Cristian O Salas, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Exploring the Effect of Halogenation in a Series of Potent and Selective A 2B Adenosine Receptor Antagonists. Journal of medicinal chemistry 66 (1) (2022)
Rubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo, Jhonny Azuaje, Abdelaziz El Maatougui, Maria Majellaro, Maria Isabel Loza, Jose Brea, Víctor Fernández-Dueñas, M Rita Paleo, Alejandro Díaz-Holguín, Beatriz García-Pinel, Ana Mallo-Abreu, Juan C Estévez, Antonio Andújar-Arias, Xerardo García-Mera, Iria Gomez-Tourino, Francisco Ciruela, Cristian O Salas, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Exploring the Effect of Halogenation in a Series of Potent and Selective A 2B Adenosine Receptor Antagonists. Journal of medicinal chemistry 66 (1) (2022)
Yongzhi Gao, Matthijs J van Haren, Ned Buijs, Paolo Innocenti, Yurui Zhang, Davide Sartini, Roberto Campagna, Monica Emanuelli, Richard B Parsons, Willem Jespers, Hugo Gutiérrez-de-Terán, Gerard van Westen, Nathaniel I Martin
Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics. Journal of medicinal chemistry 64 (17) (2021)
Ana Mallo-Abreu, Irene Reyes-Resina, Jhonny Azuaje, Rafael Franco, Aitor García-Rey, Maria Majellaro, Darío Miranda-Pastoriza, Xerardo García-Mera, Willem Jespers, Hugo Gutiérrez-de-Terán, Gemma Navarro, Eddy Sotelo
Potent and Subtype-Selective Dopamine D2 Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach. Journal of medicinal chemistry 64 (12) (2021)
Willem Jespers, Laura H Heitman, Adriaan P IJzerman, Eddy Sotelo, Gerard J P van Westen, Johan Åqvist, Hugo Gutiérrez-de-Terán
Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations. PLoS computational biology 17 (11) (2021)
Ana Mallo-Abreu, Rubén Prieto-Díaz, Willem Jespers, Jhonny Azuaje, Maria Majellaro, Carmen Velando, Xerardo García-Mera, Olga Caamaño, José Brea, María I Loza, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists. Journal of medicinal chemistry 63 (14) (2020)
Xueliang Ge, Ana Oliveira, Karin Hjort, Terese Bergfors, Hugo Gutiérrez-de-Terán, Dan I Andersson, Suparna Sanyal, Johan Åqvist
Author Correction: Inhibition of translation termination by small molecules targeting ribosomal release factors. Scientific reports 10 (1) (2020)
Ismael Rodríguez-Espigares, Mariona Torrens-Fontanals, Johanna K S Tiemann, David Aranda-García, Juan Manuel Ramírez-Anguita, Tomasz Maciej Stepniewski, Nathalie Worp, Alejandro Varela-Rial, Adrián Morales-Pastor, Brian Medel-Lacruz, Gáspár Pándy-Szekeres, Eduardo Mayol, Toni Giorgino, Jens Carlsson, Xavier Deupi, Slawomir Filipek, Marta Filizola, José Carlos Gómez-Tamayo, Angel Gonzalez, Hugo Gutiérrez-de-Terán, Mireia Jiménez-Rosés, Willem Jespers, Jon Kapla, George Khelashvilli, Peter Kolb, Dorota Latek, Maria Marti-Solano, Pierre Matricon, Minos-Timotheos Matsoukas, Przemyslaw Miszta, Mireia Olivella, Laura Perez-Benito, Davide Provasi, Santiago Ríos, Iván R Torrecillas, Jessica Sallander, Agnieszka Sztyler, Silvana Vasile, Harel Weinstein, Ulrich Zachariae, Peter W Hildebrand, Gianni De Fabritiis, Ferran Sanz, David E Gloriam, Arnau Cordomi, Ramon Guixà-Gonzaléz, Jana Selent
GPCRmd uncovers the dynamics of the 3D-GPCRome. Nature methods 17 (8) (2020)
Silvana Vasile, Anders Hallberg, Jessica Sallander, Mathias Hallberg, Johan Åqvist, Hugo Gutiérrez-de-Terán
Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists. Biomolecules 10 (4) (2020)
Willem Jespers, Grégory Verdon, Jhonny Azuaje, Maria Majellaro, Henrik Keränen, Xerardo García-Mera, Miles Congreve, Francesca Deflorian, Chris de Graaf, Andrei Zhukov, Andrew S Doré, Jonathan S Mason, Johan Åqvist, Robert M Cooke, Eddy Sotelo, Hugo Gutiérrez-de-Terán
X-Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A2A Adenosine Receptor Antagonists. Angewandte Chemie (International ed. in English) 59 (38) (2020)
María Majellaro, Willem Jespers, Abel Crespo, María J Núñez, Silvia Novio, Jhonny Azuaje, Rubén Prieto-Díaz, Claudia Gioé, Belma Alispahic, José Brea, María I Loza, Manuel Freire-Garabal, Carlota Garcia-Santiago, Carlos Rodríguez-García, Xerardo García-Mera, Olga Caamaño, Christian Fernandez-Masaguer, F Javier Sardina, Angela Stefanachi, Abdelaziz El Maatougui, Ana Mallo-Abreu, Johan Åqvist, Hugo Gutiérrez-de-Terán, Eddy Sotelo
3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition. Journal of medicinal chemistry 64 (1) (2020)
Willem Jespers, Mauricio Esguerra, Johan Åqvist, Hugo Gutiérrez-de-Terán
QligFEP: an automated workflow for small molecule free energy calculations in Q. Journal of cheminformatics 11 (1) (2019)
Zuzana Jandova, Willem Jespers, Eddy Sotelo, Hugo Gutiérrez-de-Terán, Chris Oostenbrink
Free-Energy Calculations for Bioisosteric Modifications of A3 Adenosine Receptor Antagonists. International journal of molecular sciences 20 (14) (2019)
Ana Mallo-Abreu, María Majellaro, Willem Jespers, Jhonny Azuaje, Olga Caamaño, Xerardo García-Mera, José M Brea, María I Loza, Hugo Gutiérrez-de-Terán, Eddy Sotelo
Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition. Journal of medicinal chemistry 62 (20) (2019)
Willem Jespers, Geir V Isaksen, Tor A H Andberg, Silvana Vasile, Amber van Veen, Johan Åqvist, Bjørn Olav Brandsdal, Hugo Gutiérrez-de-Terán
QresFEP: An Automated Protocol for Free Energy Calculations of Protein Mutations in Q. Journal of chemical theory and computation 15 (10) (2019)
Xueliang Ge, Ana Oliveira, Karin Hjort, Terese Bergfors, Hugo Gutiérrez-de-Terán, Dan I Andersson, Suparna Sanyal, Johan Åqvist
Inhibition of translation termination by small molecules targeting ribosomal release factors. Scientific reports 9 (1) (2019)
Rebecka Isaksson, Jens Lindman, Johan Wannberg, Jessica Sallander, Maria Backlund, Dhaniel Baraldi, Robert E Widdop, Mathias Hallberg, Johan Åqvist, Hugo Gutiérrez-de-Terán, Johan Gising, Mats Larhed
A Series of Analogues to the AT2R Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode. ChemistryOpen 8 (1) (2019)
Yasmin Shamsudin Khan, Hugo Gutiérrez-de-Terán, Johan Åqvist
Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs. Biochemistry 57 (7) (2018)
Jhonny Azuaje, Willem Jespers, Vicente Yaziji, Ana Mallo, María Majellaro, Olga Caamaño, María I Loza, María I Cadavid, José Brea, Johan Åqvist, Eddy Sotelo, Hugo Gutiérrez-de-Terán
Effect of Nitrogen Atom Substitution in A3 Adenosine Receptor Binding: N-(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective Antagonists. Journal of medicinal chemistry 60 (17) (2017)
Anne Cathrine Nøhr, Willem Jespers, Mohamed A Shehata, Leonard Floryan, Vignir Isberg, Kirsten Bayer Andersen, Johan Åqvist, Hugo Gutiérrez-de-Terán, Hans Bräuner-Osborne, David E Gloriam
The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site. Scientific reports 7 (1) (2017)
Willem Jespers, Ana Oliveira, Rubén Prieto-Díaz, María Majellaro, Johan Åqvist, Eddy Sotelo, Hugo Gutiérrez-de-Terán
Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors. Molecules (Basel, Switzerland) 22 (11) (2017)
Mauricio Esguerra, Alexey Siretskiy, Xabier Bello, Jessica Sallander, Hugo Gutiérrez-de-Terán
GPCR-ModSim: A comprehensive web based solution for modeling G-protein coupled receptors. Nucleic acids research 44 (W1) (2016)

Hugo Gutiérrez-de-Terán.css-eqlu8i{font-size:small;padding-left:4px;} (Hugo Gutierrez-de-Teran, Hugo Gutiérrez-de-Teran, Hugo Gutierrez de Teran)

Publication Activity (10 Years)

Top Topics

Top Venues

Hugo Gutiérrez-de-Terán (Hugo Gutierrez-de-Teran, Hugo Gutiérrez-de-Teran, Hugo Gutierrez de Teran)